Who We Are
Diamond Age Data Science is a team of 20+ senior-level scientists with world-class computational expertise, diverse experience from leading biopharma institutions, and recognition as trusted experts. Working closely across various scientific and technical teams, from bench scientists and CSOs to computational biologists and IT, we approach every project with a listening mindset, scientific rigor, and the ability to adapt. At Diamond Age, we aren’t just delivering analysis; we are providing the clarity, guidance, and technical outputs that support long-term productivity and scientific progress in human health and well-being.
Founder & CEO
Eleanor has been working at the cutting edge of bioinformatics for over 20 years. As founder of Diamond Age, she led the company’s evolution from a small, project-based service provider to a full-fledged consultancy that works closely with clients to tackle their most difficult research challenges.
Before founding Diamond Age, Eleanor served as the sole bioinformatician in the Center for the Development of Therapeutics at the Broad Institute of MIT and Harvard, where she helped drive drug discovery projects in cancer, cardiovascular disease, and kidney disease, among others. She also worked at the Dana-Farber Cancer Institute, where she led mid- and late-stage development of the Multiexperiment Viewer, a powerful tool for mining large genomic datasets.
Trained as a computational biologist, Eleanor has deep expertise in transcriptional profiling as well as drug discovery and development. She earned her Ph.D. bioinformatics from Oxford University under Christopher Holmes and John Quackenbush, and also holds a master’s degree in cellular and molecular biology from the University of Wisconsin-Madison.
Eleanor is on the board of directors for WEST and speaks frequently at conferences. You can read her published scientific work here.
consultant
Michael brings two perspectives to Diamond Age: the skills of a computational biologist and the expertise of a bench biochemist. His work ranges from transcriptional analysis (including both bulk and single-cell RNA-seq data) to selection of promising candidates from high-throughput small-molecule screens. Prior to joining Diamond Age, he worked on early drug discovery efforts in type 2 diabetes at the Broad Institute of MIT and Harvard, and on chemical biology approaches to understanding the roles of signaling pathways in cancer at Massachusetts General Hospital.
Michael holds a Ph.D. in biochemistry from the University of Rochester School of Medicine and Dentistry, and a B.S. from Saint Bonaventure University, also in biochemistry.
consultant
Jason Warner brings the insight of a molecular biologist and the technical acumen of an engineer to Diamond Age. In a previous role at Courtagen Life Sciences — where he was one of the first hires — he built the company’s bioinformatics pipeline and operation, including a team of 10, from scratch. He has also held senior roles in both data analysis and tech dev at many leading genomics startups, including Applied Biosystems, RainDance Technologies, Veritas Genetics, and Olaris Therapeutics.
Jason holds a Ph.D. in Cellular and Molecular Physiology from the Tufts University School of Medicine, and a B.A. in Biology from Cornell University. He completed his postdoc at Harvard Medical School.
consultant
Katie combines a passion for scientific problem-solving with years of experience handling next-generation genomic sequencing data. Before joining Diamond Age, she worked at world-leading biomedical research institutions including the Novartis Institutes for Biomedical Research (NIBR), Brigham and Women’s Hospital, and the Broad Institute of MIT and Harvard’s genome sequencing center. She also worked at Life Technologies and the genome interpretation startup Knome.
Katie holds an M.S. in computational biology from Carnegie Mellon University and a BS in both biotechnology and mathematics from Tufts University.
consultant
Mia has deep expertise in analyzing large genomic datasets, including RNA-sequencing, copy number variation, whole genome or whole-exome sequencing, and single nucleotide polymorphism data. Before joining Diamond Age, Mia was a biomolecular engineer at National Cancer Institute’s The Cancer Genome Atlas Program. She played a significant role in writing the TCGA’s landmark paper “Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas,” published in The New England Journal of Medicine.
Mia holds a Ph.D. in Biomolecular Engineering and Bioinformatics from the University of California Santa Cruz, and a B.S. in Computer Science with a concentration in Bioinformatics from the University of Delaware.
consultant
Dale has worked in Bioinformatics for over 20 years and brings a unique combination of experience in healthcare systems, the pharmaceutical industry, and academia. Before joining Diamond Age she led the computational analysis of NGS data for disease-associated variation for population screening and undiagnosed rare disease programs at Geisinger and Inova. Her prior work at Novartis and Stanford includes target identification, biomarkers of drug safety and efficacy, and genotype-phenotype relationships.
Dale has a PhD in Biochemistry from UCSF and a BS in Applied Mathematics from Yale University. She also completed a postdoc in x-ray crystallography at the University of Oxford, UK.
CONSULTANT
John brings his deep biological expertise and broad computational background to every client collaboration. As the former Director of Genomic Informatics at the Altius Institute for Biomedical Sciences, he led a skilled bioinformatics team in analyzing cutting-edge bulk and single-cell RNA-Seq assays at scale. Prior to Altius, John spent a decade at the Harvard Chan Bioinformatics Core as an analyst and Associate Director, specializing in expression, methylation, and proteomics analysis, with a focus on data visualization and management.
John holds a Ph.D. in Biology from McMaster University and a BS in Applied Biochemistry from the University of Guelph. He completed postdocs at the Whitehead Institute, MGH, and Brigham and Women’s Hospital.
CONSULTANT
Abdalla combines an enthusiasm for solving complex biological problems with an expert knowledge of cutting edge methods for omics analysis. Prior to joining Diamond Age, he spent 6 years at the National Cancer Institute as a bioinformatics analysist where he collaborated with a variety of labs on their genomics projects. Abdalla has experience with a wide range of bioinformatics methods, and specializes in single cell and spatial technologies.
Abdalla has a MS in Bioinformatics from New York University and a BS in Bioinformatics from Virginia Commonwealth University.
head of business development
You must be logged in to post a comment.